Research of the Relationship between Interleukin-18 and Type 2 Diabetic Macrovascular Complication
Zhai Shaozhong
Abstract
Zhai Shaozhong
Abstract
Objective:To study the relationship between serum Interleukin-18 and type 2 diabetic macrovascular complication (MVC).Methods:68 case of type 2 diabetes were divided into macrovascular complications group (48) and non macrovascular complicationsgroup (20) ,and 20 healthy subjects were regarded as the normal controls(NC). Interleukin-18 levels were measured using ABC-ELISA,and the factors related to diabetic macrovascular complications were analyzed by multiple stepwise logstic regressive analysis.Results:Serum Interleukin-18 level was significantly higher in type 2 diabetes group than that in the control(46.03±13.91) pg/ml vs(25.49±9.69) pg/ml,P0.01).Serum Interleukin-18 level was 50.15±12.36 pg/ml in diabetic macrovascular complications group, which was significantly higher than that in the non-diabetic macrovascular complications(Non-MVC)group(36.14±12.58 pg/ml) and in the normal controls(25.49±9.69 pg/ml)(F=32.975,P0.01).To define the independent association between the risk factors and diabetic macrovascular complications, the multiple stepwise logstic regressive analysis was used. Serum Interleukin-18 ,age, course and TG was related independently and significantly with macrovascular complications.Conclusion:The study suggested that Interleukin-18 might be an important independent risk factor for diabetic macrovascular complications.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the relationship between serum Interleukin-18 and type 2 diabetic macrovascular complication (MVC).Methods:68 case of type 2 diabetes were divided into macrovascular complications group (48) and non macrovascular complicationsgroup (20) ,and 20 healthy subjects were regarded as the normal controls(NC). Interleukin-18 levels were measured using ABC-ELISA,and the factors related to diabetic macrovascular complications were analyzed by multiple stepwise logstic regressive analysis.Results:Serum Interleukin-18 level was significantly higher in type 2 diabetes group than that in the control(46.03±13.91) pg/ml vs(25.49±9.69) pg/ml,P0.01).Serum Interleukin-18 level was 50.15±12.36 pg/ml in diabetic macrovascular complications group, which was significantly higher than that in the non-diabetic macrovascular complications(Non-MVC)group(36.14±12.58 pg/ml) and in the normal controls(25.49±9.69 pg/ml)(F=32.975,P0.01).To define the independent association between the risk factors and diabetic macrovascular complications, the multiple stepwise logstic regressive analysis was used. Serum Interleukin-18 ,age, course and TG was related independently and significantly with macrovascular complications.Conclusion:The study suggested that Interleukin-18 might be an important independent risk factor for diabetic macrovascular complications.
Key concepts: Medicine, Diabetes mellitus, Internal medicine, Type 2 diabetes, Macrovascular disease, Complication, Interleukin, Gastroenterology